Trials / Completed
CompletedNCT00109083
A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging, Multicenter Study of the Efficacy of RWJ-333369 in the Prophylaxis of Migraine
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 300 (planned)
- Sponsor
- SK Life Science, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate whether RWJ-333369 is a safe and effective treatment in reducing the number of migraine headaches when added to a person's usual medications for acute migraine headache relief.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RWJ-333369 |
Timeline
- Start date
- 2002-03-01
- Primary completion
- 2006-02-01
- Completion
- 2006-02-01
- First posted
- 2005-04-25
- Last updated
- 2012-08-02
Locations
25 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00109083. Inclusion in this directory is not an endorsement.